Procept Biorobotics Company Insiders

Procept Biorobotics Management Team Effectiveness

The company has return on total asset (ROA) of (0.1306) % which means that it has lost $0.1306 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (0.2722) %, meaning that it created substantial loss on money invested by shareholders. Procept Biorobotics' management efficiency ratios could be used to measure how well Procept Biorobotics manages its routine affairs as well as how well it operates its assets and liabilities. Return On Tangible Assets is likely to drop to -0.16 in 2026. Return On Capital Employed is likely to drop to -0.19 in 2026. At this time, Procept Biorobotics' Non Current Liabilities Other is comparatively stable compared to the past year. Change To Liabilities is likely to gain to about 7 M in 2026, whereas Total Current Liabilities is likely to drop slightly above 31.5 M in 2026. Common Stock Shares Outstanding is likely to drop to about 42 M in 2026. Net Loss is likely to drop to about (82.4 M) in 2026The majority of Procept Biorobotics Corp outstanding shares are owned by third-party entities. These institutional holders are usually referred to as non-private investors looking to secure positions in Procept Biorobotics Corp to benefit from reduced commissions. Consequently, institutional investors are subject to a different set of regulations than regular investors in Procept Biorobotics. Please pay attention to any change in the institutional holdings of Procept Biorobotics Corp as this could imply that something significant has changed or is about to change at the company. Dividend Paid And Capex Coverage Ratio is likely to drop to -21.26 in 2026. Common Stock Shares Outstanding is likely to drop to about 42 M in 2026. Net Loss is likely to drop to about (82.4 M) in 2026.

Procept Biorobotics Workforce Comparison

The company has Profit Margin (PM) of (0.28) %, which may suggest that it does not properly executes on its current pricing strategies or is unable to control all of the operational costs. This is way below average. Similarly, it shows Operating Margin (OM) of (0.28) %, which suggests for every $100 dollars of sales, it generated a net operating loss of $0.28.

Procept Biorobotics Insider Trading History

Procept Biorobotics Notable Stakeholders

String symbol = request.getParameter("s");

The success or failure of an entity such as Procept Biorobotics Corp often depends on how effective the management is. Procept Biorobotics management team is responsible for propelling the future growth in the right direction and administering and controlling the business activities and accounting for the results. Ineffective management usually contributes to failure in the company's future performance for all stakeholders equally, but most importantly, for investors. So it is important to measure the effectiveness of Procept management before purchasing its stock. In many ways, it's all about finding the answer to one important question - Are they doing the right thing right now? How would we assess whether the Procept management is utilizing all available resources in the best possible way? Also, how well is the company doing relative to others in its sector and the market as a whole? The answer can be found by analyzing a few important fundamental indicators such as return on assets and return on equity.

Please note, the imprecision that can be found in Procept Biorobotics' accounting process means that the reasonable investor should take a skeptical approach toward the financial statement analysis of Procept Biorobotics Corp. Check Procept Biorobotics' Beneish M Score to see the likelihood of Procept Biorobotics' management manipulating its earnings.

When running Procept Biorobotics' price analysis, check to measure Procept Biorobotics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Procept Biorobotics is operating at the current time. Most of Procept Biorobotics' value examination focuses on studying past and present price action to predict the probability of Procept Biorobotics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Procept Biorobotics' price. Additionally, you may evaluate how the addition of Procept Biorobotics to your portfolios can decrease your overall portfolio volatility.